期刊文献+

肺腺癌并发脑转移危险因素分析及预测模型构建

Risk factors analysis and prediction model construction of adenocarcinoma of the lung complicated with brain metastasis
下载PDF
导出
摘要 目的探究肺腺癌患者并发脑转移的独立危险因素并构建列线图的预测模型。方法选取浙江省医疗健康集团杭州医院2017年1月至2022年1月收治的肺腺癌患者235例,其中145例患者诊断为肺腺癌并发脑转移,为转移组,剩余未出现脑转移的90例患者为未转移组。对两组患者的一般资料进行统计学分析并构建Nomogram预测模型。结果两组患者的性别、T分期、肿瘤直径、进行手术治疗、Karnofsky功能状态(Karnofskyperformancestatus,KPS)评分比较差异均有统计学意义(均P<0.05)。将患者一般临床资料比较差异有统计学意义的连续变量进行受试者操作特征(receiver operating characteristic,ROC)曲线分析。结果显示肿瘤直径、KPS评分的曲线下面积(area under the curve,AUC)分别为:0.866、0.910;最佳截断值分别为:>6.36cm、≤75分。Logistic多元回归分析显示:肿瘤直径>6.36cm、KPS评分≤75、化疗(否)、手术治疗(否)、T分期T_(3)~T_(4)、性别、出现其他部分转移是肺腺癌患者合并脑转移发生的独立危险因素(均P<0.05)。将是否进行化疗、KPS评分、是否出现其他部位转移、T分期、性别、肿瘤直径、是否接受手术治疗作为构建Nomogram模型的预测因子。内部验证结果显示,Nomogram模型预测肺腺癌患者并发脑转移风险C指数为0.694(95%CI:0.213~1.858)。校准曲线显示观测值与预测值间一致性较好。Nomogram模型预测肺腺癌患者并发脑转移风险阈值>0.14,Nomogram模型提供临床净收益。结论本研究构建的列线图预测模型与实际观测数据的结果具有良好的一致性,可用于预测肺腺癌患者并发脑转移的发生。 Objective To explore the independent risk factors of patients with lung adenocarcinoma complicated with brain metastases,and construct the prediction model of the graph.Methods A total of 235 patients with lung adenocarcinoma admitted to Zhejiang Medical and Health Group Hangzhou Hospital from January 2017 to January 2022 were selected,of which 145 patients were diagnosed with lung adenocarcinoma complicated with brain metastasis,and were included in the metastatic group.The remaining 90 patients without brain metastasis were in the non-metastatic group.The general clinical data of the study samples were analyzed statistically and an Nomogram prediction model was established.Results There were statistically significant differences in gender,T stage,tumor size,surgical treatment and Karnofsky performance status(KPS)scores between the two groups(all P<0.05).Receiver operating characteristic(ROC)was analyzed with statistically significant continuous variables in the comparison table of general clinical data of patients.The results showed that the area under the curve(AUC)of tumor size and KPS score were 0.866 and 0.910,respectively.The optimal truncation values were>6.36cm,≤75,respectively.The single factor difference index was incorporated into the Logistic multiple regression model,and the results showed that:Tumor size>6.36cm,KPS score≤75,chemotherapy(no),surgical treatment(no),T stage(T3-T4),gender,and other partial metastases were independent risk factors for lung adenocarcinoma patients with brain metastases(all P<0.05).Whether chemotherapy was performed,KPS score,metastasis to other sites,T stage,sex,tumor size,and surgical treatment were used as predictors to construct a Nomogram model.The results of internal verification showed that the C-index of Nomogram model was 0.694(95%CI:0.213-1.858).The calibration curve shows a good agreement between the observed and predicted values.This Nomogram model predicted that the risk threshold of brain metastases in patients with lung adenocarcinoma was>0.14.In addition,the net clinical benefits of Nomogram models were higher than whether chemotherapy was performed,KPS score,other site metastasis,T stage,sex,tumor size,and whether surgery was performed.Conclusion The prediction model of line graph constructed in this study was in good agreement with the results of actual observation data.It can be used to predict the occurrence of brain metastases in lung adenocarcinoma patients.
作者 李兰春 房宇坤 方凯 陶刚 LI Lanchun;FANG Yukun;FANG Kai;TAO Gang(Zhejiang Medical and Health Group Hangzhou Hospital,Hangzhou 310022,Zhejiang,China;Graduate School of Zhejiang University of Traditional Chinese Medicine,Hangzhou 310053,Zhejiang,China;Department of Respiratory,the 903rd Hospital of the PLA Joint Logistic Support Force,Hangzhou 310022,Zhejiang,China;Quzhou Hospital of Zhejiang Medical and Health Group.Quzhou 324004,Zhejiang,China;Department of Comprehensive Oncology,Zhejiang Medical and Health Group Hangzhou Hospital,Hangzhou 310022,Zhejiang,China)
出处 《中国现代医生》 2023年第24期25-29,共5页 China Modern Doctor
基金 浙江省基础公益研究计划项目(LGF22H010010)。
关键词 肺腺癌 脑转移 危险因素分析 预测模型 Lung adenocarcinoma Brain metastasis Risk factor analysis Prediction model
  • 相关文献

参考文献14

二级参考文献60

  • 1邹建军,王杰军.癌症患者生活质量评价的研究现状及进展[J].癌症进展,2004,2(5):352-355. 被引量:41
  • 2AndrewsDW ScottCB SperdutoPW FlandersAE GasparLE SchellMC Werner-WasikM DemasW RyuJ BaharyJP SouhamiL RotmanM MehtaMP CurranWJJr.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase Ⅲ resuIts of the RTOG 9508 randomised trial[J].中国神经肿瘤杂志,2004,2(3):192-192. 被引量:212
  • 3胡雁,Ken Sellick.癌症康复评价系统简表中文版的信度和效度[J].中国心理卫生杂志,2006,20(2):76-80. 被引量:51
  • 4GORE E M, BAE K,WONG S J,et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: Primary analysis of Radiation Therapy Oneology Group Study RTOG 0214 [Jl. Clin Oncol, 2005,2(8 ) : 625-- 626.
  • 5BAJARD A,WESTEEL V, DUBIEZ A,et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma [J ]. Lung Cancer, 2004,45 ( 3 ) : 317-- 323.
  • 6P OTFGEN C1,EBERHARDT W,GRANNASS A,et al. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German muhicenter randomized trial [ J ]. J Clin Oncol, 2007,25 (31 ) : 4 987 -- 4 992.
  • 7MUJOOMDAR A,AUSTIN J H~MALHOTRA R et al. Clinical predictors of metastatic disease to the brain from non-small celt tung carcinoma: primary tumor size, cell type, and lymph node metastases [J]. Radiology,2007,242(3 ) : 882--888.
  • 8CERESOLI G L,RENI M,CHIESA G,et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis [ J ]. Cancer, 2002,95 ( 3 ): 605 -- 612.
  • 9ROBNETF T J,MACHTAY M, STEVENSON J P,et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma[J]. J Clin Oncol,2001,19(5): 1 344--1 349.
  • 10SAYNAK M, HUBBS J, NAM J, et al. Variability in defining T1N0 non-small cell lung cancer impacts locoregional failure and survival [J ]. Ann Thorac Surg, 2010,90(5 ) : 1 645 -- 1 649.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部